Kancera AB
F:3EE0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kancera AB
F:3EE0
|
SE |
|
Spir Group ASA
OSE:SPIR
|
NO |
|
X
|
XXL ASA
OSE:XXL
|
NO |
|
G
|
Gesco SE
XMUN:GSC1
|
DE |
|
Estika Tata Tiara Tbk PT
IDX:BEEF
|
ID |
|
Mount Logan Capital Inc
OTC:PYCFF
|
CA |
|
Prosperity Bancshares Inc
NYSE:PB
|
US |
|
H
|
Horisont Energi AS
OSE:HRGI
|
NO |
|
JGC Holdings Corp
TSE:1963
|
JP |
|
Innate Pharma SA
F:IDDA
|
FR |
|
H
|
HawkEye 360 Inc
NYSE:HAWK
|
US |
|
B
|
Beijing Shenzhou Aerospace Software Technology Co Ltd
SSE:688562
|
CN |
|
S
|
Sabuy Technology PCL
SET:SABUY
|
TH |
|
Bioxytran Inc
OTC:BIXT
|
US |
|
I
|
Italia Independent Group SpA
MIL:IIG
|
IT |
|
Sasol Ltd
NYSE:SSL
|
ZA |
|
P
|
Pure Extracts Technologies Corp
F:PUX
|
CA |
|
C
|
CoStar Group Inc
XMUN:RLG
|
US |
|
Lu-Ve SpA
F:V92
|
IT |
|
Steel Partners Holdings LP
OTC:SPLP
|
US |
|
OneWater Marine Inc
NASDAQ:ONEW
|
US |
|
EC World Real Estate Investment Trust
SGX:BWCU
|
SG |
Bankruptcy Probability
Kancera AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Kancera AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
K
|
Kancera AB
STO:KAN
|
19.4m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
459.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
187.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
87.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Kancera AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Kancera AB has no debt.
You can find a full breakdown on its Balance Sheet.
